Bora CDMO Bora CDMO

X

Find ST101 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)
7
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

ST101
Also known as: 887603-94-3, St-101, Zset1446, Zset-1446, St101, 1',3'-dihydro-2h-spiro[imidazo[1,2-a]pyridine-3,2'-inden]-2-one
Molecular Formula
C15H12N2O
Molecular Weight
236.27  g/mol
InChI Key
QZWYXEBIQWJXAR-UHFFFAOYSA-N
FDA UNII
7TTT61784C

C/EBP Beta Antagonist ST101 is a peptide antagonist of the transcription factor CCAAT/enhancer-binding protein beta (C/EBP beta), with potential antineoplastic activity. Upon administration, C/EBP beta antagonist ST101 targets and inhibits the activity of C/EBP beta. This prevents the expression of C/EBP beta target genes and proteins, including the anti-apoptotic protein B-cell lymphoma 2 (Bcl-2), cyclins and inhibitor of differentiation (ID) family of proteins, which are involved in cell proliferation, differentiation, and cell cycle regulation. This may lead to apoptosis in tumor cells. C/EBP beta is overexpressed in many cancers and plays an important role in the regulation of cell differentiation; its expression is associated with tumor cell survival and proliferation.
1 2D Structure

ST101

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
spiro[1,3-dihydroindene-2,3'-imidazo[1,2-a]pyridine]-2'-one
2.1.2 InChI
InChI=1S/C15H12N2O/c18-14-15(17-8-4-3-7-13(17)16-14)9-11-5-1-2-6-12(11)10-15/h1-8H,9-10H2
2.1.3 InChI Key
QZWYXEBIQWJXAR-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1C2=CC=CC=C2CC13C(=O)N=C4N3C=CC=C4
2.2 Other Identifiers
2.2.1 UNII
7TTT61784C
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Spiro(imidazo-(1,2-a)pyridine-3,2-indan)-2(3h)-one

2. St 101

3. St-101

4. St101 Cpd

5. Zset 1446

6. Zset1446

2.3.2 Depositor-Supplied Synonyms

1. 887603-94-3

2. St-101

3. Zset1446

4. Zset-1446

5. St101

6. 1',3'-dihydro-2h-spiro[imidazo[1,2-a]pyridine-3,2'-inden]-2-one

7. 7ttt61784c

8. Spiro[1,3-dihydroindene-2,3'-imidazo[1,2-a]pyridine]-2'-one

9. Unii-7ttt61784c

10. Spiro[imidazo[1,2-a]pyridine-3(2h),2'-[2h]inden]-2-one, 1',3'-dihydro-

11. Schembl543559

12. Chembl4297437

13. Bcp33073

14. Zinc1491487

15. St 101(zset1446)

16. Mfcd09970869

17. Cs-6039

18. Db12621

19. Sb18912

20. Hy-11013

21. Sy264852

22. A13764

23. F50512

24. Q27268838

25. St-101; Zset1446; St101; Zset 1446; St 101

26. 1',3'-dihydrospiro[imidazo[1,2-a]pyridine-3(2h),2'-[2h]inden]-2-one

27. 1,3-dihydro-2h-spiro[imidazo[1,2-a]pyridine-3,2-inden]-2-one

28. 1 Inverted Exclamation Mark ,3 Inverted Exclamation Mark -dihydro-2h-spiro[imidazo[1,2-a]pyridine-3,2 Inverted Exclamation Mark -inden]-2-one

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 236.27 g/mol
Molecular Formula C15H12N2O
XLogP31.9
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count1
Rotatable Bond Count0
Exact Mass236.094963011 g/mol
Monoisotopic Mass236.094963011 g/mol
Topological Polar Surface Area32.7 Ų
Heavy Atom Count18
Formal Charge0
Complexity475
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY